pharma bpc 157 PDA (BPC-157-Arginine) bpc 157 steroid Pharmaceutical Product

Inflammatory cell numbers decreased more rapidly in BPC-157-treated burns compared to controls or silver sulfadiazine-treated wounds

For questions about peptides or any treatment being considered, contact the office to schedule a consultation

Oral BPC-157 solves the compliance problem

Typical injectable GHK-Cu dose ranges Standard starting dose: 1 mg per day subcutaneous Conservative / beginner dose: 0.5 mg per day Intensive / wound-healing dose: 23 mg per day Upper research range: 4 mg per day (rarely exceeded) Frequency: once daily, or split into morning + evening microdoses for steadier levels Route: subcutaneous (SC) injection - typically abdomen , thigh or flank